ReviewMarine drugs2021
Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by
Review in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 33 citations in OpenAlex.
- Potential Increase in Known and Emerging Biotoxins in Marine Ecosystem Due to Climate Change and Subsequent Health Issues.Foods (Basel, Switzerland) · 2026Review
- Brevetoxin PbTx2 Modulates Oxidative Stress and Inflammatory Response in an In Vitro Human Immune Cell Line.Toxics · 2026Article
- Brevetoxin Metabolites: Emerging Toxins in French Shellfish Determined by LC-MS/MS and ELISA.Marine drugs · 2026Article
- Targeting Florida red tide: Curcumin inhibits Karenia brevis thioredoxin reductase.Plant physiology and biochemistry : PPB · 2026Article
- Comparative Quantitative Proteomic Analysis of High and Low Toxin-ProducingMarine drugs · 2025Article
- Targeted Isolation of ω-3 Polyunsaturated Fatty Acids from the Marine DinoflagellateMarine drugs · 2025Article
- Marine Algal Toxins and Public Health: Insights from Shellfish and Fish, the Main Biological Vectors.Marine drugs · 2024Review
- Article
- Acute Effects of Brevetoxin-3 Administered via Oral Gavage to Mice.Marine drugs · 2023Article
- Review of Harmful Algal Blooms (HABs) Causing Marine Fish Kills: Toxicity and Mitigation.Plants (Basel, Switzerland) · 2023Review
- Identification and cross-species comparison ofToxicon: X · 2023Article
- Five Years Monitoring the Emergence of Unregulated Toxins in Shellfish in France (EMERGTOX 2018-2022).Marine drugs · 2023Article
- The Effects of the Harmful Algal Bloom SpeciesToxins · 2022Article
- Current Trends and New Challenges in Marine Phycotoxins.Marine drugs · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent decades, more than 130 potentially toxic metabolites originating from dinoflagellate species belonging to the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.